While we will talk more about the Dow project in Alberta on Sunday, one of the problems that the stock faces in the light of the announcement is largely unrelated, which is the growing expectation that margins in 2022 will be significantly lower than in 2021. This is the view coming out of the recent EPCA meeting and as the ethylene/propylene chart below shows, monomer pricing is already weakening in the US as production ramps back up following the recent storms – we note in Exhibit 1 from today's daily report the squeeze on ethylene margins as prices fall, while costs rise. But it is also worth noting that margins remain quite healthy, while well below their highs. Those companies who built new ethylene capacity in the US over the last 5 years would have had a margin similar to the current level shown in Exhibit 1 in an optimistic capital case.
The move by China to reduce overall energy consumption is an effort to make progress on emissions but also to curtail energy demand where there is either a shortage or an over-dependence on coal-based power generation. The immediate impact in the acetic acid chain is clear from exhibit 1 in today's daily report.If these moves in China become more widespread they could reduce the significant near-term surpluses that the country has in polyolefins, PTA and PET. Why consume either expensive or high carbon power to make products that you currently cannot sell and that are either being sold at a loss or flowing into inventory? China has the structure to make decisions like this. Should this happen we could perhaps see a recovery in polyolefins pricing and PET pricing in China – as seen for the acetic chain in the exhibit below. Keeping production in line with the demand in China is important in the very near term as the fall out from the Evergrande collapse suggests that demand into the property market has been inflated and will likely correct negatively – increasing surpluses. China can force material into the export market, if it can find containers and if it is willing to operate at break-even margins. Better to curtail production.
The Baystar polyethylene start-up date is consistent with the guidance that the company has been providing for a while, but it still leaves the venture with an ethylene surplus until that time and while the ethylene has been placed, according to the company, the ethylene that it has displaced will likely keep some downward pressure on US ethylene pricing until the polymer plant starts up (all things being equal). Even when the polymer plant starts, the US is expected to have a net ethylene surplus and we would expect exports to continue and prices to reflect levels to make the exports possible.
USGC ethylene spot prices have weakened since reaching a multi-year peak in mid-April, something we have discussed for some time. This week's downtick in propylene values is a bit more unique as it has occurred alongside weakness in other monomer markets, which is a general trend that appears likely to gain momentum. Most monomer markets are weakening from recent 2Q21 highs in the US. We broadly find an increasing level of support for our view that many commodity chemical product prices will peak for the year in 2Q21. Exhibit 1 in our Daily Report shows an Asia arbitrage that should allow US ethylene to move to Asia, but is in the potential to take it because of local Asia surpluses, Asia prices will remain under pressure, although ethylene values in this region are fast approaching costs. We will soon be back to the previous equilibrium in an oversupplied ethylene market, where the economics of Asia production sets prices, and US exporters make a margin based on their cost advantage. The question now is how long it is before polymer prices follow.
The weakness in US monomer pricing has stalled this week, and buyers and sellers may be exploring marginal export or derivative export opportunities at these levels. Further weakness will come if attempts to export only serve to undermine pricing in the markets they are targeting. Underlying demand remains very strong and this is a supply-driven issue as US ethylene plants run back towards full rates and incremental refinery supply impacts the benzene and propylene markets. See today's report which includes detailed commentary on methanol in addition to the products in the chart.
Pessimism in the Asia ethylene market is a bad sign for ethylene vs. other US monomers. Those in the US with ethylene surpluses may need to fight a bit harder to find homes for the excess product in the US. We have not focused on the cost curve for a while as markets have been tight and global costs have not been an influence in the market for some time. The US has plenty of dry powder, in that export prices can fall significantly before they approach ethane-based costs, and can fall below production costs outside the US – especially in Asia – and still generate a margin for the US sellers. But that would mean more downside for US spot pricing and it may be enough to create some surpluses and some downward pressure on US derivative pricing. The caveat, of course, is that we had the same setup last year, albeit with less new capacity in Asia, and the summer hurricane season quickly wiped away any US surplus. A better understanding of the current cost curve and relative regional pricing can be found in our Weekly from Monday.
The volatility in propylene was something we predicted months ago – there are simply too many moving parts in the market today to predict incremental supply/demand dynamics. We remain of the view that refining rates will improve further over the coming months to address the increasing demand for gasoline and this could swing propylene back in the other direction. See today's report for more on this.